Cells obtained from menstrual blood, termed 'endometrial regenerative cells' (ERCs), are capable of restoring blood flow in an animal model of advanced peripheral artery disease, according to a study published today in Journal of Translational Medicine. When circulation-blocked mice were treated with ERC injections, circulation and functionality were restored.
Critical limb ischemia, an advanced form of peripheral artery disease, causes approximately 150,000 amputations per year in the US. Currently there are no medical or surgical interventions that are effective in the advanced stages of the disease. ERCs are cells taken from menstrual blood that are capable of forming into at least 9 different tissue types, including heart, liver and lung. Their discovery won the 'Medicine Research Award of the Year' award for BioMed Central's Research Awards in 2007.
Dr. Michael Murphy, a vascular surgeon from Indiana University and lead author of this study has already performed clinical trials with adult stem cells for patients with peripheral artery disease. He stated, "The advantage of ERCs is that they can be used in an 'off the shelf' manner, meaning they can be delivered to the point of care, do not require matching, and are easily injectable without the need for complex equipment."
The experiments were performed as a collaboration between University of Western Ontario, Scripps Research Institute, Indiana University, and several other academic centers. The ERC cell population is currently being developed by the US publicly traded company Medistem Inc, who supported these studies.
"We are proud of assembling such a strong, clinically experienced team to contribute to these studies" said Dr. Thomas Ichim, CEO of Medistem. "Dr. Ewa Carrier and Suman Kambhampati are hematologists who use stem cells on a regular basis, Dr. Angle is a vascular surgeon, who like Dr. Murphy sees CLI on a daily basis, and Dr. Amit Patel has performed numerous cardiac stem cell clinical trials. With such a team that understands not only the science, but also the practical implementation, we feel we are well positioned to translate this discovery into a practical therapy in the near future".
Article: Michael P Murphy, Hao Wang, Amit N Patel, Suman Kambhampati, Niren Angle, Kyle W Chan, Annette M Marleau, Andrew Pyszniak, Ewa Carrier, Thomas E Ichim and Neil H Riordan, 'Allogenic Endometrial Regenerative Cells: An "Off the Shelf Solution" For Critical Limb Ischemia?', Journal of Translational Medicine
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- Family Holiday Survival: 12 Ways To Deal With That Climate Change Denier
- A Vegetarian Carnivorous Plant...Wait, What?
- Falsifiability And The Integrity Of Physics
- Wave-Particle Duality And Quantum Uncertainty - Two Sides Of The Same Mystery?
- Dr. Ozvorkian And The Amoebas
- Guest Post: Ben Allanach, On Open Access
- How Does Prostate Cancer Happen?
- "Glad someone finally is calling out this clowns. String theory is pure math, and has no testable..."
- "Michael Martinez: 1-in-6 Americans can expect to be needlessly killed by their doctors. You can't..."
- "There is no definitive proof that irrefutably confirms that humans didn't exist 400,000 years ago..."
- "As a layman, I have some faith in Einstien. The reasons are because the well established experimental..."
- "When I run into the religious Climate Change believers I just start showing them one of the dozens..."
- Air pollution linked to congenital defects
- Blocking excessive division of mitochondria reduces liver cell death in cholestasis
- The math of how decisiona 'cascade' in social networks
- iPads and other Light-emitting e-readers detrimentally shift circadian clock
- Cope with climate change by shape-shifting